Literature DB >> 21165330

P2X and P2Y Receptors Mediate Contraction Induced by Electrical Field Stimulation in Feline Esophageal Smooth Muscle.

Young Rae Cho1, Hyeon Soon Jang, Won Kim, Sun Young Park, Uy Dong Sohn.   

Abstract

It is well-known that electrical field stimulation (EFS)-induced contraction is mediated by a cholinergic mechanism and other neurotransmitters. NO, ATP, calcitonin gene-related peptide (CGRP), and substance P are released by EFS. To investigate the purinergic mechanism involved in the EFS-induced contraction, purinegic receptors antagonists were used. Suramine, a non-selective P2 receptor antagonist, reduced the contraction induced by EFS. NF023 (10(-7)~10(-4) M), a selective P2X antagonist, inhibited the contraction evoked by EFS. Reactive blue (10(-6)~10(-4) M), selective P2Y antagonist, also blocked the contraction in a dose-dependent manner. In addition, P2X agonist α,β-methylene 5'-adenosine triphosphate (αβMeATP, 10(-7)~10(-5) M) potentiated EFS-induced contraction in a dose-dependent manner. P2Y agonist adenosine 5'-[β-thio]diphosphate trilithium salt (ADPβS, 10(-7)~10(-5) M) also potentiated EFS-induced contractions in a dose-dependent manner. Ecto-ATPase activator apyrase (5 and 10 U/ml) reduced EFS-induced contractions. Inversely, 6-N,N-diethyl-D-β,γ-dibromomethylene 5'-triphosphate triammonium (ARL 67156, 10(-4) M) increased EFS-induced contraction. These data suggest that endogenous ATP plays a role in EFS-induced contractions which are mediated through both P2X-receptors and P2Y-receptors stimulation in cat esophageal smooth muscle.

Entities:  

Keywords:  ATP; Calcium; Electrical field stimulation; G protein; P2 receptor; Smooth muscle

Year:  2010        PMID: 21165330      PMCID: PMC2997417          DOI: 10.4196/kjpp.2010.14.5.311

Source DB:  PubMed          Journal:  Korean J Physiol Pharmacol        ISSN: 1226-4512            Impact factor:   2.016


  38 in total

1.  Regulation of adenosine 5'-triphosphate (ATP)-gated P2X(4) receptors on tracheal smooth muscle cells.

Authors:  Miyuki Nagaoka; Masayuki Nara; Tsutomu Tamada; Hiroaki Kume; Tetsuya Oguma; Toshiaki Kikuchi; Jamal Zaini; Takuya Moriya; Masakazu Ichinose; Gen Tamura; Toshio Hattori
Journal:  Respir Physiol Neurobiol       Date:  2009-02-14       Impact factor: 1.931

Review 2.  Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide.

Authors:  J M Lundberg
Journal:  Pharmacol Rev       Date:  1996-03       Impact factor: 25.468

3.  Characterisation of subtypes of the P2X and P2Y families of ATP receptors in the foetal human heart.

Authors:  Y Bogdanov; A Rubino; G Burnstock
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

4.  Differential distribution of two ATP-gated channels (P2X receptors) determined by immunocytochemistry.

Authors:  L Vulchanova; U Arvidsson; M Riedl; J Wang; G Buell; A Surprenant; R A North; R Elde
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

5.  Endogenous adenosine inhibits evoked substance P release from perifused networks of myenteric ganglia.

Authors:  N A Moneta; T J McDonald; M A Cook
Journal:  Am J Physiol       Date:  1997-01

6.  Towards a revised nomenclature for P1 and P2 receptors.

Authors:  B B Fredholm; M P Abbracchio; G Burnstock; G R Dubyak; T K Harden; K A Jacobson; U Schwabe; M Williams
Journal:  Trends Pharmacol Sci       Date:  1997-03       Impact factor: 14.819

7.  Molecular identification and pharmacological characterization of adenosine receptors in the guinea-pig colon.

Authors:  M Kadowaki; M Takeda; K Tokita; K Hanaoka; M Tomoi
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

8.  Inhibitory effect of nonsteroidal anti-inflammatory drugs on adenosine transport in vascular smooth muscle cells.

Authors:  Rachel Wai-Sum Li; Sai-Wang Seto; Alice Lai-Shan Au; Yiu-Wa Kwan; Shun-Wan Chan; Simon Ming-Yuen Lee; Chung-Ming Tse; George Pak-Heng Leung
Journal:  Eur J Pharmacol       Date:  2009-04-18       Impact factor: 4.432

9.  Calcium-dependent release of arachidonic acid in response to purinergic receptor activation in airway epithelium.

Authors:  E R Lazarowski; R C Boucher; T K Harden
Journal:  Am J Physiol       Date:  1994-02

10.  Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor.

Authors:  J B Schachter; Q Li; J L Boyer; R A Nicholas; T K Harden
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

View more
  5 in total

1.  The Signaling Mechanism of Contraction Induced by ATP and UTP in Feline Esophageal Smooth Muscle Cells.

Authors:  Tae Hoon Kwon; Hyunwoo Jung; Eun Jeong Cho; Ji Hoon Jeong; Uy Dong Sohn
Journal:  Mol Cells       Date:  2015-05-27       Impact factor: 5.034

2.  Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats.

Authors:  Luca Antonioli; Maria Cecilia Giron; Rocchina Colucci; Carolina Pellegrini; Deborah Sacco; Valentina Caputi; Genny Orso; Marco Tuccori; Carmelo Scarpignato; Corrado Blandizzi; Matteo Fornai
Journal:  PLoS One       Date:  2014-12-30       Impact factor: 3.240

Review 3.  Important roles of P2Y receptors in the inflammation and cancer of digestive system.

Authors:  Han-Xing Wan; Jian-Hong Hu; Rei Xie; Shi-Ming Yang; Hui Dong
Journal:  Oncotarget       Date:  2016-05-10

4.  P2Y12 and P2Y13 receptors involved in ADPβs induced the release of IL-1β, IL-6 and TNF-α from cultured dorsal horn microglia.

Authors:  Pei-Wen Liu; Ming-Xia Yue; Rui Zhou; Juan Niu; Du-Juan Huang; Tao Xu; Pei Luo; Xiao-Hong Liu; Jun-Wei Zeng
Journal:  J Pain Res       Date:  2017-07-26       Impact factor: 3.133

Review 5.  Pathophysiological Role of Purinergic P2X Receptors in Digestive System Diseases.

Authors:  Qimin An; Gengyu Yue; Xiaoxu Yang; Jun Lou; Weixi Shan; Jianhong Ding; Zhe Jin; Yanxia Hu; Qian Du; Qiushi Liao; Rui Xie; Jingyu Xu
Journal:  Front Physiol       Date:  2021-12-24       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.